India to launch National Policy on Research and Development and Innovation in Pharma-MedTech
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
The medical device sector is considered as one of the sunrise sectors in the country
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
Subscribe To Our Newsletter & Stay Updated